Affiliate sales and option exercise at KYMR (NASDAQ: KYMR) — multiple 10b5-1 trades

robot
Abstract generation in progress

A recent SEC Form 144 filing from Kymera Therapeutics, Inc. (NASDAQ: KYMR) indicates proposed and recent sales of Common Stock by an affiliate. The filing details an exercise of 300 shares on April 22, 2026, and several 10b5-1 sales totaling a significant number of shares, with proceeds amounting to millions of dollars, occurring between March 2, 2026, and April 15, 2026. These transactions, primarily attributed to Jeremy Chadwick, suggest a pre-planned divestment activity by an insider.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin